Skip to main content

Advertisement

SpringerLink
Log in

Current Management of Hepatocellular Cancer

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver, being the fifth most frequent cancer worldwide. It usually occurs in the setting of chronic liver disease and has a poor prognosis if untreated. Following the diagnosis, this disease requires multidisciplinary management. Orthotopic liver transplantation is theoretically the best treatment for early, unresectable HCC. However, the major practical obstacle is the extreme shortage of organs, which makes this a practical option only in selected patients. In this report we describe new advancements in diagnosis, classification, and treatment that have emerged in the field of HCC in recent years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153–156.

    Article  CAS  PubMed  Google Scholar 

  2. Befeler AS, Di Bisceglie AM: Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002, 122:1609–1619.

    Article  PubMed  Google Scholar 

  3. • Liu CJ, Kao JH: Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors. J Chin Med Assoc 2007, 70:141–145. This is an interesting review on epidemiology and the pathogenic role of viral factors in hepatocarcinogenesis.

    Article  CAS  PubMed  Google Scholar 

  4. Fong TL, Kanel GC, Conrad A, et al.: Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology 1994, 19:554–557.

    Article  CAS  PubMed  Google Scholar 

  5. Ming L, Thorgeirsson SS, Gail MH, et al.: Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology 2002, 36:1214–1220.

    Article  CAS  PubMed  Google Scholar 

  6. Hassan MM, Hwang LY, Hatten CJ, et al.: Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002, 36:1206–1213.

    Article  CAS  PubMed  Google Scholar 

  7. Ohata K, Hamasaki K, Toriyama K, et al.: Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 2003, 97:3036–3043.

    Article  PubMed  Google Scholar 

  8. Davila JA, Morgan RO, Shaib Y, et al.: Diabetes has been found to increase the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005, 54:533–539.

    Article  CAS  PubMed  Google Scholar 

  9. Kew MC: The development of hepatocellular cancer in humans. Cancer Surv 1986, 5:719–739.

    CAS  PubMed  Google Scholar 

  10. Di Bisceglie AM: Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 1995, 15:64–69.

    Article  PubMed  Google Scholar 

  11. El-Serag HB: Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002, 36:S74–S83.

    Article  PubMed  Google Scholar 

  12. Beasley RP: Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988, 61:1942–1956.

    Article  CAS  PubMed  Google Scholar 

  13. El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999, 340:745–750.

    Article  CAS  PubMed  Google Scholar 

  14. Allen J, Venook A: Hepatocellular carcinoma: epidemic and treatment. Curr Oncol Rep 2004, 6:177–183.

    Article  PubMed  Google Scholar 

  15. Tanaka Y, Hanada K, Mizokami M, et al.: Inaugural article: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 2002, 99:15584–15589.

    Article  CAS  PubMed  Google Scholar 

  16. • Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003, 362:1907–1917. This is a positive paper on management of HCC.

    Article  PubMed  Google Scholar 

  17. Makuuchi M, Sano K: The surgical approach to HCC: our progress and results in Japan. Liver Transpl 2004, 10:46–52.

    Article  Google Scholar 

  18. Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepatology 2005, 42:1208–1236.

    Article  PubMed  Google Scholar 

  19. •• Mazzaferro V, Regalia E, Doci R, et al.: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693–699. This study introduced the Milan criteria and showed that liver transplantation is an effective treatment for small, unresectable HCC in patients with cirrhosis.

    Article  CAS  PubMed  Google Scholar 

  20. Llovet JM, Di Bisceglie AM, Bruix J, et al.: Design and endpoints of clinical trials in hepatocellular carcinoma. Panel of Experts in HCC-Design Clinical Trials. J Natl Cancer Inst 2008, 100:698–711.

    Article  PubMed  Google Scholar 

  21. Bruix J, Sherman M, Llovet JM, et al.: EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001, 35:421–430.

    Article  CAS  PubMed  Google Scholar 

  22. Marrerro JA, Fontana RJ, Barrat A: Prognosis of hepatocellular carcinoma: comparison of 7 staging system in an American cohort. Hepatology 2005, 41:707–716.

    Article  Google Scholar 

  23. Cillo U, Vitale A, Grigoletto F: Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 2006, 44:723–731.

    Article  PubMed  Google Scholar 

  24. •• Llovet JM, Ricci S, Mazzaferro V, et al.; SHARP Investigators Study Group: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359:378–390. This article shows that sorafenib improves overall survival for patients with advanced HCC.

    Article  CAS  PubMed  Google Scholar 

  25. Llovet JM, Bruix J: Molecular targeted therapies in hepatocellular carcinoma. Hepatology 2008, 48:1312–1327.

    Article  CAS  PubMed  Google Scholar 

  26. Marin-Hargreaves G, Azoulay D, Bismuth H: Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hematol 2003, 47:13–27.

    Article  PubMed  Google Scholar 

  27. De Carlis L, Giacomoni A, Pirotta V, et al.: Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg 2003, 196:887–897.

    Article  PubMed  Google Scholar 

  28. Vauthey JN, Chaoui A, Do KA, et al.: Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000, 127:512–519.

    Article  CAS  PubMed  Google Scholar 

  29. Farges O, Belghiti J, Kianmanesh R, et al.: Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003, 237:208–217.

    Article  PubMed  Google Scholar 

  30. Oldhafer KJ, Lang H, Malago M, et al.: Ex situ resection and resection of the in situ perfused liver: are there still indications? Chirurg 2001, 72:131–137.

    Article  CAS  PubMed  Google Scholar 

  31. Ringe B, Weimann A, Tusch G, Pichlmayr R: Resection versus transplantation for malignancy of liver and bile duct. In Surgery for Gastrointestinal Cancer. Edited by Wanebo HJ. Philadelphia: Lippincott-Raven; 1997:513–524.

  32. Bismuth H, Chiche L, Adam R, et al.: Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993, 218:145–151.

    Article  CAS  PubMed  Google Scholar 

  33. Ojogho ON, So SK, Keeffe EB, et al.: Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival. Arch Surg 1996, 131:935–939; discussion 939–941.

    CAS  PubMed  Google Scholar 

  34. Molmenti EP, Klintmalm GB: Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl 2002, 8:736–748.

    Article  PubMed  Google Scholar 

  35. Plessier A, Codes L, Consigny Y, et al.: Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma. Liver Transpl 2004, 10:S86–S90.

    Article  PubMed  Google Scholar 

  36. Pawlik TM, Delman KA, Vauthey JN, et al.: Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 2005, 11:1086–1092.

    Article  PubMed  Google Scholar 

  37. Jonas S, Bechstein WO, Steinmuller T, et al.: Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 2001, 5:1080–1086.

    Article  Google Scholar 

  38. Bruix J, Fuster J, Llovet JM: Liver transplantation for hepatocellular carcinoma: Foucault pendulum versus evidence-based decision. Liver Transpl 2003, 7:700–702.

    Article  Google Scholar 

  39. Yao FY, Bass NM, Nikolai B, et al.: Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002, 8:873–883.

    Article  PubMed  Google Scholar 

  40. Yao FY, Xiao L, Bass NM, et al.: Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007, 7:2587–2596.

    Article  CAS  PubMed  Google Scholar 

  41. •• Mazzaferro V, Llovet JM, Miceli R, et al.; Metroticket Investigator Study Group: Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009, 10:35–43. This study showed that more patients with HCC could be candidates for transplantation if the current dual (yes/no) approach to candidacy, based on the strict Milan criteria, was replaced with a more precise estimation of survival contouring individual tumor characteristics and use of the up-to-seven criteria.

    Article  PubMed  Google Scholar 

  42. Sarasin FP, Giostra E, Mentha G, Hadengue A: Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology 1998, 28:436–442.

    Article  CAS  PubMed  Google Scholar 

  43. Saab S, Wang V, Ibrahim AB, et al.: MELD score predict 1-years patient survival post-orthotopic liver transplantation. Liver Transpl 2003, 9:473–476.

    Article  PubMed  Google Scholar 

  44. Yao FY, Bass NM, Ascher NL, Roberts JP: Liver transplantation for hepatocellular carcinoma: Lesson from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy. Liver Transpl 2004, 10:621–630.

    Article  PubMed  Google Scholar 

  45. Ryu M, Shimamura Y, Kinoshita T, et al.: Therapeutic results of resection, transcatheter arterial embolization and percutaneous transhepatic ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 1997, 27:251–257.

    Article  CAS  PubMed  Google Scholar 

  46. Livraghi T, Solbiati L, Meloni MF, et al.: Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003, 226:441–451.

    Article  PubMed  Google Scholar 

  47. • Poon RT, Fan ST, Tsang FH, Wong J: Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon’s perspective. Ann Surg 2002, 235:466–486. This article details how recent advances in locoregional therapies have led to a major breakthrough in the management of HCC.

    Article  PubMed  Google Scholar 

  48. Van Kleek EJ, Schwartz JM, Rayhill SC, et al.: Liver transplantation for hepatocellular carcinoma: a survey of practices. J Clin Gastroenterol 2006, 40:643–647.

    Article  PubMed  Google Scholar 

  49. Broering DC, Wilms C, Bok P, et al.: Evolution of donor morbidity in living related liver transplantation: a single-center analysis of 165 cases. Ann Surg 2004, 240:1013–1024; discussion 1024–1026.

    Article  PubMed  Google Scholar 

  50. • Trotter JF, Wachs M, Everson GT, Kam I: Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002, 346:1074–1082. LDLT has rapidly emerged as an accepted treatment option for selected patients with end-stage liver disease.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

Supported by a grant from Pineta Grande Hospital, Castel Volturno, Caserta, Italy.

Disclosure

We declare that the contents of our manuscript have not been submitted simultaneously to another journal, have not been accepted for publication elsewhere, and have not already been published. We already disclose any potential or actual personal, political, or financial interest in the material, information, or techniques described in the article.

Author information

Authors and Affiliations

  1. Department of Surgery, Pineta Grande Hospital, Castel Volturno, Caserta, Italy

    Bernardino Rampone, Beniamino Schiavone & Giuseppe Confuorto

  2. via Sabato de Vita, 63, 84080, Pellezzano, Salerno, Italy

    Bernardino Rampone

Authors
  1. Bernardino Rampone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beniamino Schiavone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giuseppe Confuorto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernardino Rampone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rampone, B., Schiavone, B. & Confuorto, G. Current Management of Hepatocellular Cancer. Curr Oncol Rep 12, 186–192 (2010). https://doi.org/10.1007/s11912-010-0094-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-010-0094-3

Keywords

Search

Navigation